Table of Contents Table of Contents
Previous Page  2278-2279 / 2437 Next Page
Information
Show Menu
Previous Page 2278-2279 / 2437 Next Page
Page Background

Alectinib vs Crizotinib trial

Brain metastases in patients with ALK-positive NSCLC

Peters

et al 2017, N Engl J Med; 377: 829-38

cumulative incidence of CNS progression

1 … 2268-2269 2270-2271 2272-2273 2274-2275 2276-2277 2278-2279 2280-2281 2282-2283 2284-2285 2286-2287 2288-2289 2290-2291 … 2436-2437  FlippingBook